Evaluation of a pre-filled diluent syringe (MixPro®) among patient/carer users and nurses
References
- Cancio MI, Reiss UM, Nathwani AC, Davidoff AM, et al. Developments in the treatment of hemophilia B: focus on emerging gene therapy. Appl Clin Genet 2013; 6: 91-101.
- Mannucci PM, Franchini M. Is haemophilia B less severe than haemophilia A? Haemophilia 2013; 19(4): 499-502.
- Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, et al. Guidelines for the management of hemophilia. Haemophilia 2013; 19(1): e1-47.
- Chalmers, A. Haemophilia A and B: disease differences and the use of prophylactic therapy. Available from http://www.hemophiliareport.com/pdf/HEMR0101.pdf (accessed 11 October 2017).
- Furlan R, Krishnan S, Vietri J. Patient and parent preferences for characteristics of prophylactic treatment in hemophilia. Patient Prefer Adherence 2015; 9: 1687-94.
- Pabinger-Fasching I. The story of a unique molecule in hemophilia A: recombinant single-chain factor VIII. Thromb Res 2016; 141 Suppl 3: S2-S4.
- Shima M, Lillicrap D, Kruse-Jarres R. Alternative therapies for the management of inhibitors. Haemophilia 2016; 22 Suppl 5: 36-41.
- Saxena K. Barriers and perceived limitations to early treatment of hemophilia. J Blood Med 2013; 4: 49-56.
- Cimino E, Linari S, Malerba M, Halimeh S, et al. Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries. Patient Prefer Adherence 2014; 8: 1713-20.
- Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7(4): 392-6.
- Lindvall K, Colstrup L, Wollter IM, Klemenz G, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia 2006; 12(1): 47-51.
- Vidovic N, Musso R, Klamroth R, Enriquez MM, et al. Postmarketing surveillance study of KOGENATE Bayer with Bio-Set in patients with haemophilia A: evaluation of patients' satisfaction after switch to the new reconstitution system. Haemophilia 2010; 16(1): 66-71.
- Khair K, Meerabeau L, Gibson F. Self-management and skills acquisition in boys with haemophilia. Health Expect 2015; 18(5): 1105-13.
- Schrijvers LH, Beijlevelt-van der Zande M, Peters M, Schuurmans MJ, et al. Learning intravenous infusion in haemophilia: experience from the Netherlands. Haemophilia 2012; 18(4): 516-20.
- Riva S, Nobili A, Djade CD, Mancuso ME, et al. Cognitive and psychological profiles in treatment compliance: a study in an elderly population with hemophilia. Clin Interv Aging 2015; 10: 1141-6.
- European Medicines Agency. NovoEight: EPAR – product information. Available from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002719/WC500157553.pdf Accessed 24 February 2017).
- European Medicines Agency. NovoSeven: EPAR – product information. Available from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000074/WC500030873.pdf (accessed 24 February 2017).
- Munn J, Khair K, Scott A, Shoemark R, et al. Patient and caregiver perceptions of a pre-filled diluent syringe (MixPro). J Haem Pract 2016; 3(1): doi: 10.17225/jhp00073.
- European Medicines Agency. Refixia: EPAR – product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004178/WC500232816.pdf (accessed 11 October 2017).
- Makwana S, Basu B, Makasana Y, Dharamsi A. Prefilled syringes: an innovation in parenteral packaging. Int J Pharm Investig 2011; 1(4): 200-6.
- Zadbuke N, Shahi S, Gulecha B, Padalkar A, et al. Recent trends and future of pharmaceutical packaging technology. J Pharm Bioallied Sci 2013; 5(2): 98-110.
- Khair K. Evaluating a self infusion device for children with haemophilia. Paediatr Nurs 2006; 18(10): 19-20.
- Fernandez-Arias I, Kim HK. Factor VIII delivery devices in haemophilia A. Barriers and drivers for treatment adherence. Farm Hosp 2016; 40(n06): 579-603.
- Musso R, Santoro R, Coppola A, Marcucci M, et al. Patient preference for needleless factor VIII reconstitution device: the Italian experience. Int J Gen Med 2010; 3: 203-8.
DOI: https://doi.org/10.17225/jhp00106 | Journal eISSN: 2055-3390
Language: English
Page range: 12 - 23
Published on: May 31, 2018
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2018 Debra Pollard, Kate Khair, Cléa Percier, Yen Wong, Robyn Shoemark, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.